Apr 28, 2026 06:30AM
Apr 28, 2026 06:30AM
Jul 28, 2025 08:45AM
Jul 28, 2025 08:45AM
Jun 23, 2025 06:59AM
May 8, 2025 06:50AM
Apr 22, 2025 06:59AM Aclaris Therapeutics (ACRS) Secures U.S. Food and Drug Administration IND Clearance for ATI-052
Apr 22, 2025 06:59AM
Jan 30, 2025 04:04PM
Jan 30, 2025 04:01PM
Jan 10, 2024 07:00AM
Jan 10, 2024 07:00AM
Nov 13, 2023 10:39AM
Nov 8, 2022 07:00AM Aclaris Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
Nov 18, 2021 04:01PM
Sep 23, 2021 08:33AM
Aug 30, 2021 07:54AM
Jun 9, 2021 09:27AM
Jun 8, 2021 05:54PM
Jan 20, 2021 09:20AM
Jan 19, 2021 05:44PM After-Hours Stock Movers 01/19: (NFLX) (CKPT) (PCAR) Higher; (HSTO) (BLRX) (ACRX) Lower (more...)
Jul 8, 2020 09:24AM
Jul 7, 2020 05:49PM
Jul 7, 2020 04:02PM
Jul 7, 2020 04:01PM
Jun 17, 2020 09:27AM
Jun 17, 2020 07:04AM
Jun 17, 2020 07:01AM Aclaris Therapeutics Supports Investigator-Initiated Clinical Trial of ATI-450 for Cytokine Release Syndrome in Hospitalized Patients with COVID-19
Nov 7, 2019 04:01PM
Oct 24, 2019 04:51PM
Oct 24, 2019 04:01PM
Oct 22, 2019 09:30AM
Oct 8, 2019 05:03PM
Oct 8, 2019 05:01PM
Sep 18, 2019 07:51PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aclaris Therapeutics, Carbonite, GTT Communications, and Just Energy and Encourages Investors to Contac
Sep 16, 2019 04:17PM
Sep 16, 2019 04:15PM
Sep 10, 2019 07:30PM
Sep 3, 2019 10:30PM
Aug 27, 2019 08:00AM
Aug 18, 2019 07:30PM
Aug 11, 2019 07:25PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 3M Company, Aclaris Therapeutics, and Curaleaf and Encourages Investors to Contact the Firm
Aug 8, 2019 04:01PM
Aug 5, 2019 09:30PM
Jul 30, 2019 08:20PM
Jul 30, 2019 04:39PM
Jul 30, 2019 04:01PM
Jul 9, 2019 07:03AM
Jul 9, 2019 07:00AM Aclaris Therapeutics Announces Issuance of Additional Orange Book Listable Patent Covering RHOFADE® (Oxymetazoline Hydrochloride) Cream, 1%
Jul 7, 2019 09:30PM

323,009 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All